Group 1 - The core viewpoint of the articles highlights the performance and market position of Chao Yan Co., Ltd. in the medical device industry, showcasing its financial metrics and competitive standing [1][2] - As of August 25, Chao Yan Co., Ltd. closed at 28.18 yuan, with a rolling price-to-earnings (PE) ratio of 76.26, significantly higher than the industry average of 55.91 [1][2] - The company's total market capitalization is reported at 12.07 billion yuan, ranking it 96th in the medical device sector based on PE ratio [1][2] Group 2 - The company reported a revenue of 98.43 million yuan for Q1 2025, reflecting a year-on-year increase of 28.69%, and a net profit of 39.32 million yuan, up 47.70% year-on-year [1] - The gross profit margin for the company stands at 73.83%, indicating strong profitability in its operations [1] - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with a well-established market presence and customer base [1]

从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均56.58倍，行业中值39.97倍，超研股份排 名第94位。 股东方面，截至2025年3月31日，超研股份股东户数26755户，较上次减少23411户，户均持股市值35.28 万元，户均持股数量2.76万股。 汕头市超声仪器研究所股份有限公司的主营业务是医学影像设备、工业无损检测设备的研发、生产和销 售。公司的主要产品是工业超声、医用超声、X射线、配附件。经过多年积累，公司已拥有较高的市场 知名度和稳定的客户基础，工业超声无损检测产品被评为广东省名牌产品；2022年，公司凭借"复杂超 大构件高精密无损检测新技术及其重大应用"项目获得国家工业和信息化部颁发的国防技术发明奖二等 奖。 8月15日，超研股份今日收盘27.83元，上涨1.76%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到75.31倍，总市值119.20亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入9843.24万元，同比28.69%；净利润3932.20万 元，同比47.70%，销售毛利率73.83%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13超研 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Chao Yan Co., Ltd. in the medical device industry, noting its recent stock price increase and market position [1] - As of August 11, Chao Yan Co., Ltd. closed at 28.68 yuan, up 5.13%, with a rolling PE ratio of 77.61, marking a new low in 114 days, and a total market capitalization of 12.284 billion yuan [1] - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Chao Yan Co., Ltd. at the 97th position in the industry ranking [1] Group 2 - As of the first quarter of 2025, 118 institutions hold shares in Chao Yan Co., Ltd., with a total holding of 71,100 shares valued at 0.02 billion yuan [1] - The main business of Chao Yan Co., Ltd. includes the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products being industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong provincial brand [1] - In 2022, Chao Yan Co., Ltd. received the second prize for the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on new technology for high-precision non-destructive testing of complex large components [1] Group 3 - The latest performance report for the first quarter of 2025 shows that Chao Yan Co., Ltd. achieved operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, a year-on-year increase of 47.70%, with a gross profit margin of 73.83% [1]

8月8日，超研股份今日收盘27.28元，下跌2.57%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到73.83倍，总市值116.85亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入9843.24万元，同比28.69%；净利润3932.20万 元，同比47.70%，销售毛利率73.83%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13超研股份73.8380.279.03116.85亿行业平均 55.7051.864.84117.31亿行业中值39.0838.492.8857.46亿1九安医疗11.1411.270.88188.05亿2英科医疗 15.5716.791.39246.03亿3山东药玻16.0616.111.85151.90亿4振德医疗16.3115.371.0459.21亿5新华医疗 16.4415.241.34105.38亿6奥美医疗17.0016.661.7561.43亿7九强生物17.7016.462.1787.65亿8维力医疗 18.1019.342.2842.44亿9奥泰生物18.4319.441.4958.79亿10康德莱18.7118.721. ...

汕头市超声仪器研究所股份有限公司的主营业务是医学影像设备、工业无损检测设备的研发、生产和销 售。公司的主要产品是工业超声、医用超声、X射线、配附件。经过多年积累，公司已拥有较高的市场 知名度和稳定的客户基础，工业超声无损检测产品被评为广东省名牌产品；2022年，公司凭借"复杂超 大构件高精密无损检测新技术及其重大应用"项目获得国家工业和信息化部颁发的国防技术发明奖二等 奖。 最新一期业绩显示，2025年一季报，公司实现营业收入9843.24万元，同比28.69%；净利润3932.20万 元，同比47.70%，销售毛利率73.83%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13超研股份72.3978.718.86114.58亿行业平均 54.8949.974.71114.46亿行业中值37.0636.862.6754.89亿1九安医疗10.9311.060.86184.50亿2英科医疗 14.2315.351.27224.88亿3新华医疗15.7214.571.28100.77亿4山东药玻15.9516.001.83150.91亿5奥美医疗 16.2315.911.6758.64亿6振德医疗16 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Chao Yan Co., Ltd. in the medical device industry, noting its current stock price and market capitalization [1][2] - As of July 30, Chao Yan Co., Ltd. closed at 27.22 yuan, with a rolling PE ratio of 73.66, marking a new low in 17 days, and a total market value of 11.659 billion yuan [1] - The average PE ratio for the medical device industry is 55.15, with a median of 37.48, placing Chao Yan Co., Ltd. at the 94th position in the industry ranking [1][2] Group 2 - As of March 31, 2025, Chao Yan Co., Ltd. had 26,755 shareholders, a decrease of 23,411 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The main business of Chao Yan Co., Ltd. includes the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products being industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, Chao Yan Co., Ltd. received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on new technology for high-precision non-destructive testing of complex large components [1] - For the first quarter of 2025, the company reported revenue of 98.43 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.32 million yuan, up 47.70%, with a gross profit margin of 73.83% [1]

Company Overview - Chao Yan Co., Ltd. closed at 27.17 yuan, up 1.95%, with a rolling PE ratio of 73.53, marking a new low in 14 days, and a total market value of 11.638 billion yuan [1] - The company operates in the medical device industry, which has an average PE ratio of 55.41 and a median of 37.94, placing Chao Yan at the 96th position in the industry ranking [1] - As of the first quarter of 2025, 118 institutions held shares in Chao Yan, with a total holding of 71,100 shares valued at 0.02 billion yuan [1] Business Operations - Chao Yan specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment [1] - The main products include industrial ultrasound, medical ultrasound, X-ray, and related accessories [1] - The company has established a strong market presence and stable customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand [1] - In 2022, the company received a second-class National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Financial Performance - In the first quarter of 2025, Chao Yan reported operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69% [1] - The net profit for the same period was 39.3220 million yuan, reflecting a year-on-year growth of 47.70% [1] - The sales gross margin stood at 73.83% [1]

Core Viewpoint - Chao Yan Co., Ltd. has seen its stock price rise to 26.63 yuan, with a rolling PE ratio of 72.07, marking a new low in 63 days, and a total market capitalization of 11.406 billion yuan [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and stable customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] - For Q1 2025, the company reported revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, up 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.42, with a median of 37.44, positioning Chao Yan Co., Ltd. at 96th place in the industry ranking [1] - The static PE ratio for Chao Yan Co., Ltd. is 78.35, and the price-to-book ratio is 8.82 [2] - The total market capitalization of the medical device industry is 106.60 billion yuan [2]

Core Viewpoint - Chao Yan Co., Ltd. has a closing price of 24.78 yuan, down 1.82%, with a rolling PE ratio of 67.06 times and a total market value of 10.614 billion yuan, indicating a higher valuation compared to the industry average [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received the second prize of the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Financial Performance - For the first quarter of 2025, the company reported operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, a year-on-year increase of 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, positioning Chao Yan Co., Ltd. at the 96th rank within the industry [1][2] - The industry average market value is 10.675 billion yuan, while the median market value is 5.063 billion yuan [2]

Group 1 - The core viewpoint of the news is that Chao Yan Co., Ltd. has a high rolling price-to-earnings (PE) ratio of 70.66, significantly above the industry average of 50.64, indicating a premium valuation in the medical device sector [1][2] - As of June 9, the company's stock closed at 26.11 yuan, with a market capitalization of 11.184 billion yuan, reflecting a 1.28% increase [1] - The company has experienced a net outflow of main funds amounting to 245.27 million yuan on June 9, with a total outflow of 2,328.49 million yuan over the past five days [1] Group 2 - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, and X-ray equipment [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, up 47.70% year-on-year, with a gross profit margin of 73.83% [1]